Four positives for black market drug in Vuelta a Costa Rica
GW-501516 detected in unidentified riders
The Costa Rican Cycling Federation (FECOCI) issued an official statement that confirms🐬 four “Adverse Analytical Findings” following the anti-doping controls taken during the 48th edition of the Vuelta Ciclista Internacional a Costa Rica, a UCI 2.1 road cycling tour held last December.
“We are just messengers”, said FECOCI’s President Hernán Solano to local newspapers. “The UCI asked us to veri♋fy that the four riders were correctly notified and now it is a process between the riders and the UCI."
Even though the names and details haven’t been revealed yet, a local journali♍st has cited “an unidentifie🙈d official source” saying all four cases - Costa Rican riders - came out with the same adverse result for GW-501516.
RusVelo's Valery Kaikov became the 168澳洲5最👍新开奖结果:first 𝓡cyclist to face a sanction for the drug after an ou🐻t-of-competition sample taken on March 17, 20🤪13 showed traces of the substance.
The doping substance which was recently identified by the World Anti-doping Agency is a weight-loss drug that was never approved by the pharmaceutical company, Glaxo, which produced it because🦩 of toxicity detected during the pre-clinical 💫tests.
168澳洲5最新开奖结果:WADA ♚issued a serious warnཧing in March that revealed the presence of the substance on the black market and confirmed several AAFs on athletes who had acces෴s to and used it as a perfo🧸rmance enhancement.
Th♊e press release from the Costa Rica Cycling Federation reminded that the possible penalties might vary from a min🐬imum two-year ban for a first-time cheater to a lifetime ban if the person already served a sanction in the past.
The latest race content, interviews, features, reviews and expe🔯rt buying guides, dওirect to your inbox!
The cyclists i💞nvolved may now ask to for “B” sample analysis, or accept the initial result, in which case, the Costa Rican Cycling Anti-doping Commission will determine the peꩲnalties.